IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

SIMONE, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.694
NA - Nord America 2.355
AS - Asia 800
AF - Africa 32
SA - Sud America 23
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.928
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.227
GB - Regno Unito 1.180
CN - Cina 398
IT - Italia 360
SE - Svezia 325
DE - Germania 306
CA - Canada 122
FI - Finlandia 114
KR - Corea 105
IE - Irlanda 77
HK - Hong Kong 74
SG - Singapore 61
FR - Francia 60
IN - India 58
RU - Federazione Russa 53
UA - Ucraina 49
TR - Turchia 48
DK - Danimarca 41
EU - Europa 40
BE - Belgio 32
NG - Nigeria 28
PL - Polonia 28
NL - Olanda 27
JP - Giappone 22
AU - Australia 17
CO - Colombia 14
ES - Italia 11
VN - Vietnam 8
GR - Grecia 7
TW - Taiwan 7
IL - Israele 6
RO - Romania 6
BG - Bulgaria 5
BR - Brasile 5
CI - Costa d'Avorio 4
ID - Indonesia 4
NZ - Nuova Zelanda 4
AT - Austria 3
CH - Svizzera 3
MX - Messico 3
CL - Cile 2
HN - Honduras 2
MD - Moldavia 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BO - Bolivia 1
GL - Groenlandia 1
HR - Croazia 1
IR - Iran 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 5.966
Salva come PNG Salva come JPEG
Città #
Southend 1.087
Chandler 331
Houston 177
Ashburn 169
Fairfield 164
Wilmington 157
Seattle 142
Milan 132
Ann Arbor 117
Princeton 113
Woodbridge 102
Toronto 100
Beijing 85
Dublin 75
Helsinki 63
Hong Kong 62
Nanjing 45
Phoenix 43
Cambridge 38
Grafing 38
Mountain View 37
Redmond 36
Bengaluru 32
Des Moines 31
Boardman 30
Dearborn 29
Singapore 29
Lekki 28
Warsaw 28
Jinan 27
Shanghai 27
Brussels 25
Shenyang 25
Somerville 23
Redwood City 21
Bitonto 19
Guangzhou 19
Sakarya 19
Hangzhou 18
Norwalk 18
Andover 17
New York 17
Ottawa 17
Seongnam 17
Frankfurt am Main 16
Medford 15
Bogotá 14
Kiez 14
Nanchang 14
Eitensheim 13
Changsha 12
Jacksonville 12
Hebei 11
Ningbo 11
Serra 11
Hamburg 10
Roxbury 10
San Diego 10
Zhengzhou 10
Los Angeles 9
Silver Spring 9
Hanover 8
Falls Church 7
Rome 7
Seoul 7
Tianjin 7
Athens 6
Taizhou 6
Wako 6
Berlin 5
Bridge 5
Cagliari 5
Columbia 5
Durham 5
Mumbai 5
Suwon 5
Taipei 5
Tel Aviv 5
Abidjan 4
Bogen 4
Catania 4
Central 4
Chicago 4
Dong Ket 4
Florence 4
Fremont 4
Huntington Station 4
Kilburn 4
Margão 4
Nutley 4
Pskov 4
Tappahannock 4
Tokyo 4
Turin 4
Wembley 4
Auburn Hills 3
Chengdu 3
Hefei 3
Jiaxing 3
Kunming 3
Totale 4.212
Salva come PNG Salva come JPEG
Nome #
GENERAZIONE E CORREZIONE DI CELLULE STAMINALIPLURIPOTENTI INDOTTE NON VIRALI DA PAZIENTE SMA COMEMODELLO DI MALATTIA E SORGENTE PER LA TERAPIA CELLULARE 320
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model 314
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms 226
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches 225
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 214
IPSC-derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1 188
Direct reprogramming of adult somatic cells into other lineages: past evidence and future perspectives 180
Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives 177
Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS 167
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype 166
Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications? 164
Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS 154
ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development 144
Embryonic stem cell–derived neural stem cells improve spinal muscular atrophy phenotype in mice 134
Therapeutic Development in Amyotrophic Lateral Sclerosis 134
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 133
Direct reprogramming of human astrocytes into neural stem cells and neurons 132
Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases 132
Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy 128
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms 115
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 107
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 105
Neural stem cells derived from genetically engineered lineage-selectable Es cells improves the phenotype of a mouse model of spinal muscular atrophy 104
Genetic correction of spinal muscular atrophy-induced pluripotent stem cells and motoneurons as a disease model and cell source for transplantation 104
A model for motor neuron degeneration and treatment of Spinal Muscular Atrophy using human induced pluripotent stem cells 103
Beta-lactam antibiotic offer neuroprotection in a spinal muscular atrophy mouse model by multiple mechanisms 101
Pluripotent engineered stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice 98
Development of a therapeutic approach for Spinal Muscular Atrophy with Respiratory Distress (SMARD1) using human induced pluripotent stem cell-derived neural stem cells and motor neurons 98
Beta lactam antibiotic ameliorates spinal muscular atrophy phenotype in a mouse model by multiple mechanisms 97
Neuroprotection in spinal muscular atrophy (SMA) using neural stem cells as a therapeuthic approach 97
Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells 97
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis 95
Motor neurons from human spinal muscular atrophy–induced pluripotent stem cells free of vector and transgenic sequences as a model and cell source for transplantation 95
Directing human astrocytes into neural stem cells and neurons as possible tool for repair in CNS diseases 95
Transplantation of neural stem cells derived from genetically engineered, lineage-selectable ES cells improves spinal muscular atrophy 93
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis 93
Targeted gene correction of spinal muscular atrophy induced pluripotent stem cells and motoneurons as cell source for therapy 92
Gene Corrected Spinal Muscular Atrophy-Induced Pluripotent Stem Cells and Motoneuron as a Model and Cell Source for Transplantation (IN8-2.002) 92
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 89
Molecular therapeutic strategies for spinal muscular atrophies : Current and future clinical trials 89
Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA) 89
Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis 88
Motoneurons from human spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences as a model and cell source for transplantation 88
MFN2-related neuropathies: clinical features, molecular pathogenesis and therapeutic perspectives 87
Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy δ7 mouse model phenotype 86
Systemic transplantation of c-kit+ cells can ameliorate the phenotype of a mouse model of Amyotrophic Lateral Sclerosis 79
Generation of motoneurons from spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences : in vitro and In vivo analysis 77
Pluripotent stem cell-based models of spinal muscular atrophy 77
Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation 70
The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review 69
In vitro and in vivo analysis of motoneurons obtained from human-spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences 66
null 4
null 3
null 3
null 3
null 3
null 3
null 3
null 3
null 3
null 3
Totale 6.398
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019184 0 0 0 0 0 0 0 0 0 0 0 184
2019/2020941 94 33 54 89 77 76 56 95 181 114 51 21
2020/2021695 33 31 49 20 62 60 85 60 79 33 114 69
2021/2022766 45 64 24 47 40 54 39 25 127 86 62 153
2022/2023934 124 124 85 107 110 153 26 52 108 12 25 8
2023/2024548 21 38 36 68 149 68 21 33 25 33 55 1
Totale 6.398